The US price of Cocamidopropyl Betaine (CAPB) is projected to decrease in February xxxx, following a rise in January, driven by multiple factors. CAPB, a mild surfactant widely used in the pharmaceutical and healthcare industries, is valued for its gentle cleansing, foaming, and thickening properties. It is a key component in medicated shampoos, antiseptic cleansers, wound care formulations, and dermatological products, particularly benefiting baby care, sensitive skin treatments, and hospital-grade hygiene solutions due to its non-irritating and skin-friendly nature.
Key Takeaways
-
CAPB price in the U.S. is expected to decrease by over xx in February xxxx due to inflationary pressures and shifts in consumer spending.
-
Rising U.S. inflation led to reduced discretionary spending, affecting demand for pharmaceuticals and personal care products.
-
Volatile tariffs and fluctuating import duties on CAPB from Asian countries have disrupted supply chains and created procurement uncertainty.
As a major importer of CAPB, the United...
